68-5

91/120

) Aoki J, Iguchi Y, Urabe T, Yamagami H, Todo K, Fujimoto S, Idomari K, Kaneko N, Iwanaga T, Terasaki T, Tanaka R, Yamamoto N, Tsujino A, Nomura K, Abe K, Uno M, Okada Y, Matsuoka H, Yamagata S, Yamamoto Y, Yonehara T, Inoue T, Yagita Y, Kimura K: ADS investigators. Cilostazol uncovers covert atrial fibrillation in non-cardioembolic stroke. J Neurol Sci, 2020; 413: 116796.) Yoritaka A, Hayashi T, Fusegi K, Hattori N: Prospective follow up of the patients with Schizophrenia accompanied by Parkinsonism. 25th World congress on Parkinson’s disease and related disorders. Neurobiol Aging, 2020; 2: S0197-4580(20)30210-4.) Yoritaka A, Yasushi Shimo, Hatano T, Hattori N: Motor/Non-motor Symptoms and Progres‑sion in Patients with Parkinson’s Disease: Prevalence and Risks in a Longitudinal Study. Parkinson’s disease, 2020; Article ID 2735361.) Bautista JMP, Oyama G, Nuermaimaiti M, Sekimoto S, Sasaki F, Hatano T, Nishioka K, Ito M, Umemura A, Ishibashi Y, Shimo Y, Hattori N: Rescue Levodopa/Carbidopa Intes‑tinal Gel for Secondary Deep Brain Stimula‑tion Failure. J Mov Disord, 2020; 13: 57-61. doi: 10.14802/jmd.19051. ) Bhidayasiri R, Panyakaew P, Trenkwalder C, Jeon B, Hattori N, Jagota P, Wu YR, Moro E, Lim SY, Shang H, Rosales R, Lee JY, Thit WM, Tan EK, Lim TT, Tran NT, Binh NT, Phoumindr A, Boonmongkol T, Phokaewva‑rangkul O, Thongchuam Y, Vorachit S, Plengsri R, Chokpatcharavate M, Fernandez HH: Delivering patient-centered care in Parkinson’s disease: Challenges and consensus from an international panel. Parkinsonism Relat Disord, 2020; 72: 82-87. doi:10.1016/j.parkreldis.2020.02.013. ) Chakravarthy KV, Chaturvedi R, Agari T, Iwamuro H, Reddy R, Matsui A: Single arm prospective multicenter case series on the use of burst stimulation to improve pain and motor symptoms in Parkinson’s disease. Bioelectron Med, 2020; 6: 18.) Hatta K. Delirium. In: Management of Sleep Disorders in Psychiatry, eds. Amit Chopra, Piyush Das, and Karl Doghramji. Oxford University Press, New York, 2020. ISBN: 9780190929671 ) Amo T, Oji Y, Saiki S, Hattori N: Metabo‑lomic analysis data of MPP+-exposed SH- SY5Y cells using CE-TOFMS. Data Brief, 2020; 34: 106707. doi:10.1016/j.dib.2020.106707. ) Andica C, Kamagata K, Hatano T, Saito Y, Uchida W, Ogawa T, Takeshige-Amano H, Hagiwara A, Murata S, Oyama G, Shimo Y, Umemura A, Akashi T, Wada A, Kumamaru KK, Hori M, Hattori N, Aoki S: Neurocogni‑tive and psychiatric disorders-related axonal degeneration in Parkinson’s disease. J Neurosci Res, 2020; 98: 936-949. doi: 10.1002/jnr.24584.) Aoki J, Iguchi Y, Urabe T, Yamagami H, Todo K, Fujimoto S, Idomari K, Kaneko N, Iwanaga T, Terasaki T, Tanaka R, Yamamoto N, Tsujino A, Nomura K, Abe K, Uno M, Okada Y, Matsuoka H, Yamagata S, Yamamoto Y, Yonehara T, Inoue T, Yagita Y, Kimura K, ADS investigators: Cilostazol Addition to Aspirin could not Reduce the Neurological Deterioration in TOAST Subtypes: ADS Post-Hoc Analysis. J Stroke Cerebrovasc Dis, 2020; 30: 105494.of bipolar disorder: Japanese expert consensus. Bipolar Disord, 2020; 22: 822-830. 25) Sakurai H, Uchida H, Kato M, Suzuki T, Baba H, Watanabe K, Inada K, Kikuchi T, Katsuki A, Kishida I, Sugawara Kikuchi Y, Yasui- Furukori N: Medical Education Panel of the Japanese Society of Clinical Neuropsycho‑pharmacology. Pharmacological management of depression: Japanese expert consensus. J Affect Disord, 2020; 266: 626-632. 26) Shukuzawa H, Baba H, Maeshima H, Shimano T, Inoue M, Saida T, Natsume S, Suzuki T: Gender Differences in the Effects of Cortisol and Dehydroepiandrosterone on Brain Derived Neurotrophic Factor in Patients with Major Depression. Juntendo Medical Journal, 2020; 66; 424-430.〈Books〉 1Neurology〈Original Articles〉 1 2 3 4 5 6 7 8 9 10) Cossu D, Yokoyama K, Tomizawa Y, Momotani E, Hattori N. Author Correction: Altered humoral immunity to mycobacterial antigens in Japanese patients affected by inflammatory 541